Insider · CIK 0001843539

Celebi John

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001843539

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-19	FTHFaeth Therapeutics, Inc.F Tax Payment	Director, PRESIDENT AND CEO	FTax Payment	−5,558 sh	$0.48	−$2,645.608	105,862
2025-02-14	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+360K sh	—	—	360,000
2024-12-20	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+355K sh	—	—	355,000
2024-02-15	FTHFaeth Therapeutics, Inc.F Tax Payment	Director, PRESIDENT AND CEO	FTax Payment	−5,891 sh	$0.79	−$4,653.89	105,420
2024-02-15	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+315K sh	—	—	315,000
2024-02-15	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+166K sh	—	—	165,889
2023-09-11	FTHFaeth Therapeutics, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+500 sh	$0.85	+$425	111,311
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+51.9K sh	—	—	110,003
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+21.3K sh	—	—	131,303
2023-02-15	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+90K sh	—	—	90,000
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+51.9K sh	—	—	106,007
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+21.3K sh	—	—	127,307
2023-02-15	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+90K sh	—	—	90,000
2023-02-15	FTHFaeth Therapeutics, Inc.F Tax Payment	Director, PRESIDENT AND CEO	FTax Payment	−20.5K sh	$1.50	−$30.7K	110,811
2022-02-15	FTHFaeth Therapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+53.9K sh	—	—	54,114
2022-02-15	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+162K sh	—	—	161,600
2021-02-03	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+417K sh	—	—	416,666

Recent filings

Accepted (ET)
Feb 264
Celebi John0001415889-25-005728
SEC(opens sec.gov)
Feb 144
Celebi John0001415889-25-004223
SEC(opens sec.gov)
Dec 234
Celebi John0001415889-24-030067
SEC(opens sec.gov)
Feb 164
Celebi John0001415889-24-004235
SEC(opens sec.gov)
Sep 134
Celebi John0001209191-23-049192
SEC(opens sec.gov)
Sep 114
Celebi John0001209191-23-048966
SEC(opens sec.gov)
Mar 294/A
Celebi John0001209191-23-021541
SEC(opens sec.gov)
Feb 174
Celebi John0001209191-23-010731
SEC(opens sec.gov)
Feb 174
Celebi John0001209191-22-010976
SEC(opens sec.gov)
Feb 54
Celebi John0001209191-21-008080
SEC(opens sec.gov)

Companies

Faeth Therapeutics, Inc.Director, PRESIDENT AND CEOFTH

Address

C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH BLVD, SUITE 125

ROCKVILLE, MD, 20850